The Zeus Modified Two-Tiered Testing (MTTT-2) ELISA system is an FDA-cleared assay that has been shown to reduce the number of missed clinically positive samples compared with the Standard Two-Tiered ...
PORTOLA VALLEY, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, the leading nonprofit funder of Lyme disease research in the US, today announced results from two independent ...
Lyme disease is a high-incidence infectious disease with a global prevalence of 14.5% of the world's population. Two-tier serology is currently the primary diagnostic test for Lyme disease; however, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback